Control of chronic Mycobacterium tuberculosis infection by CD4 KLRG1 - IL-2-secreting central memory cells

Journal of Immunology

Volumn 190, Issue 12, 2013, Pages 6311-6319

  Lindenstrøm, Thomas ^a   Knudsen, Niels Peter Hell ^a   Agger, Else Marie ^a   Andersen, Peter ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; KLRG1 ANTIGEN; L SELECTIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; BCG VACCINATION; CD4+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EXHAUSTION; FEMALE; GROWTH INHIBITION; IMMUNITY; INFECTION CONTROL; LYMPH NODE; LYMPHOCYTE PROLIFERATION; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TREATMENT DURATION; TUBERCULOSIS;

ANIMALS; BCG VACCINE; CD4-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; IMMUNOLOGIC MEMORY; INTERLEUKIN-2; MICE; MYCOBACTERIUM TUBERCULOSIS; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTE SUBSETS; TUBERCULOSIS;

EID: 84879105286     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300248     Document Type: Article

References (62)

1. WHO. 2011. Global Tuberculosis Control. WHO report 2011. World Health Organization, Geneva, Switzerland.
2. Colditz, G. A., C. S. Berkey, F. Mosteller, T. F. Brewer, M. E. Wilson, E. Burdick, and H. V. Fineberg. 1995. The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics 96: 29-35.
3. Colditz, G. A., T. F. Brewer, C. S. Berkey, M. E. Wilson, E. Burdick, H. V. Fineberg, and F. Mosteller. 1994. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 271: 698-702. (Pubitemid 24061706)
4. Fine, P. E. 1995. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346: 1339-1345.
5. Trunz, B. B., P. E. M. Fine, and C. Dye. 2006. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a metaanalysis and assessment of cost-effectiveness. Lancet 367: 1173-1180.
6. Brooks, J. V., A. A. Frank, M. A. Keen, J. T. Bellisle, and I. M. Orme. 2001. Boosting vaccine for tuberculosis. Infect. Immun. 69: 2714-2717. (Pubitemid 32239748)
7. Kipnis, A., S. Irwin, A. A. Izzo, R. J. Basaraba, and I. M. Orme. 2005. Memory T lymphocytes generated by Mycobacterium bovis BCG vaccination reside within a CD4 CD44lo CD62 ligand(hi) population. Infect. Immun. 73: 7759-7764. (Pubitemid 41587682)
8. Sterne, J. A. C., L. C. Rodrigues, and I. N. Guedes. 1998. Does the efficacy of BCG decline with time since vaccination? Int. J. Tuberc. Lung Dis. 2: 200-207. (Pubitemid 28123518)
9. Aronson, N. E., M. Santosham, G. W. Comstock, R. S. Howard, L. H. Moulton, E. R. Rhoades, and L. H. Harrison. 2004. Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: A 60-year follow-up study. JAMA 291: 2086-2091. (Pubitemid 38580151)
10. Billeskov, R., T. T. Elvang, P. L. Andersen, and J. Dietrich. 2012. The HyVac4 subunit vaccine efficiently boosts BCG-primed anti-mycobacterial protective immunity. PLoS ONE 7: e39909.
11. Brennan, M. J., B. Clagett, H. Fitzgerald, V. Chen, A. Williams, A. A. Izzo, and L. F. Barker. 2012. Preclinical evidence for implementing a prime-boost vaccine strategy for tuberculosis. Vaccine 30: 2811-2823.
12. Rowland, R., and H. McShane. 2011. Tuberculosis vaccines in clinical trials. Expert Rev. Vaccines 10: 645-658.
13. Crampin, A. C., J. R. Glynn, and P. E. M. Fine. 2009. What has Karonga taught us? Tuberculosis studied over three decades. Int. J. Tuberc. Lung Dis. 13: 153-164.
14. Donald, P. R. 2004. Childhood tuberculosis: the hidden epidemic. Int. J. Tuberc. Lung Dis. 8: 627-629. (Pubitemid 38625074)
15. Gallant, C. J., A. Cobat, L. Simkin, G. F. Black, K. Stanley, J. Hughes, T. M. Doherty, W. A. Hanekom, B. Eley, N. Beyers, et al. 2010. Impact of age and sex on mycobacterial immunity in an area of high tuberculosis incidence. Int. J. Tuberc. Lung Dis. 14: 952-959.
16. Akbar, A. N., and S. M. Henson. 2011. Are senescence and exhaustion inter-twined or unrelated processes that compromise immunity? Nat. Rev. Immunol. 11: 289-295.
17. Wherry, E. J., J. N. Blattman, K. Murali-Krishna, R. van der Most, and R. Ahmed. 2003. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77: 4911-4927. (Pubitemid 36402840)
18. Argüello, R. J., M. C. Albareda, M. G. Alvarez, G. Bertocchi, A. H. Armenti, C. Vigliano, P. C. Meckert, R. L. Tarleton, and S. A. Laucella. 2012. Inhibitory receptors are expressed by Trypanosoma cruzi-specific effector T cells and in hearts of subjects with chronic Chagas disease. PLoS ONE 7: e35966.
19. Jurado, J. O., I. B. Alvarez, V. Pasquinelli, G. J. Martínez, M. F. Quiroga, E. Abbate, R. M. Musella, H. E. Chuluyan, and V. E. García. 2008. Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis. J. Immunol. 181: 116-125.
20. Sakai, S., I. Kawamura, T. Okazaki, K. Tsuchiya, R. Uchiyama, and M. Mitsuyama. 2010. PD-1-PD-L1 pathway impairs T(h)1 immune response in the late stage of infection with Mycobacterium bovis bacillus Calmette-Guérin. Int. Immunol. 22: 915-925.
21. Schreiber, H. A., P. D. Hulseberg, J. Lee, J. Prechl, P. Barta, N. Szlavik, J. S. Harding, Z. Fabry, and M. Sandor. 2010. Dendritic cells in chronic mycobacterial granulomas restrict local anti-bacterial T cell response in a murine model. PLoS ONE 5: e11453.
22. Smith, P., C. M. Walsh, N. E. Mangan, R. E. Fallon, J. R. Sayers, A. N. J. McKenzie, and P. G. Fallon. 2004. Schistosoma mansoni worms induce anergy of T cells via selective up-regulation of programmed death ligand 1 on macrophages. J. Immunol. 173: 1240-1248. (Pubitemid 38924302)
23. Reiley, W. W., S. Shafiani, S. T. Wittmer, G. Tucker-Heard, J. J. Moon, M. K. Jenkins, K. B. Urdahl, G. M.Winslow, and D. L.Woodland. 2010. Distinct functions of antigen-specific CD4 T cells during murine Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA 107: 19408-19413.
24. Day, C. L., D. A. Abrahams, L. Lerumo, E. Janse van Rensburg, L. Stone, T. O'rie, B. Pienaar, M. de Kock, G. Kaplan, H. Mahomed, et al. 2011. Functional capacity of Mycobacterium tuberculosis -specific T cell responses in humans is associated with mycobacterial load. J. Immunol. 187: 2222-2232.
25. Millington, K. A., J.A. Innes, S. Hackforth, T. S.C. Hinks, J. J.Deeks,D. P. S.Dosanjh, V. Guyot-Revol, R. Gunatheesan, P. Klenerman, and A. Lalvani. 2007. Dynamic relationship between IFN-γ and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load. J. Immunol. 178: 5217-5226. (Pubitemid 46595306)
26. Sester, U., M. Fousse, J. Dirks, U. Mack, A. Prasse, M. Singh, A. Lalvani, and M. Sester. 2011. Whole-blood flow-cytometric analysis of antigen-specific CD4 T-cell cytokine profiles distinguishes active tuberculosis from non-active states. PLoS ONE 6: e17813.
27. Kagina, B. M. N., B. Abel, M. Bowmaker, T. J. Scriba, S. Gelderbloem, E. Smit, M. Erasmus, N. Nene, G. Walzl, G. Black, et al. 2009. Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response. Vaccine 27: 5488-5495.
28. Soares, A. P., T. J. Scriba, S. Joseph, R. Harbacheuski, R. A. Murray, S. J. Gelderbloem, A. Hawkridge, G. D. Hussey, H. Maecker, G. Kaplan, and W. A. Hanekom. 2008. Bacillus Calmette-Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles. J. Immunol. 180: 3569-3577.
29. +) T-cell memory responses induced by BCG vaccination of newborns. J. Infect. Dis. 207: 1084-1094.
30. +) T-cell subsets that mediate immunological memory to Mycobacterium tuberculosis infection in mice. Infect. Immun. 68: 621-629.
31. Duffy, D., A. Dawoodji, E. M. Agger, P. Andersen, J. Westermann, and E. B. Bell. 2009. Immunological memory transferred with CD4 T cells specific for tuberculosis antigens Ag85B-TB10.4: persisting antigen enhances protection. PLoS ONE 4: e8272.
32. Lázár-Molnár, E., B. Chen, K. A. Sweeney, E. J. Wang, W. J. Liu, J. Lin, S. A. Porcelli, S. C. Almo, S. G. Nathenson, and W. R. Jacobs, Jr. 2010. Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis. Proc. Natl. Acad. Sci. USA 107: 13402-13407.
33. Weinrich Olsen, A., L. A. H. van Pinxteren, L. Meng Okkels, P. Birk Rasmussen, and P. Andersen. 2001. Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6. Infect. Immun. 69: 2773-2778. (Pubitemid 32332164)
34. Davidsen, J., I. Rosenkrands, D. Christensen, A. Vangala, D. Kirby, Y. Perrie, E. M. Agger, and P. Andersen. 2005. Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6′-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responses. Biochim. Biophys. Acta 1718: 22-31. (Pubitemid 41698893)
35. Dietrich, J., C. Aagaard, R. Leah, A. W. Olsen, A. Stryhn, T. M. Doherty, and P. Andersen. 2005. Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy. J. Immunol. 174: 6332-6339. (Pubitemid 40663826)
36. Lindenstrøm, T., E. M. Agger, K. S. Korsholm, P. A. Darrah, C. Aagaard, R. A. Seder, I. Rosenkrands, and P. Andersen. 2009. Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells. J. Immunol. 182: 8047-8055.
37. Elvang, T., J. P. Christensen, R. Billeskov, T. Thi Kim Thanh Hoang, P. Holst, A. R. Thomsen, P. Andersen, and J. Dietrich. 2009. CD4 and CD8 T cell responses to the M. tuberculosis Ag85B-TB10.4 promoted by adjuvanted subunit, adenovector or heterologous prime boost vaccination. PLoS ONE 4: e5139.
38. Roederer, M., J. L. Nozzi, and M. C. Nason. 2011. SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A 79: 167-174.
39. Odorizzi, P. M., and E. J. Wherry. 2012. Inhibitory receptors on lymphocytes: insights from infections. J. Immunol. 188: 2957-2965.
40. Seder, R. A., P. A. Darrah, and M. Roederer. 2008. T-cell quality in memory and protection: implications for vaccine design. Nat. Rev. Immunol. 8: 247-258. (Pubitemid 351432801)
41. Henao-Tamayo, M. I., D. J. Ordway, S. M. Irwin, S. B. Shang, C. Shanley, and I. M. Orme. 2010. Phenotypic definition of effector and memory T-lymphocyte subsets in mice chronically infected with Mycobacterium tuberculosis. Clin. Vaccine Immunol. 17: 618-625.
42. Orme, I. M. 2010. The Achilles heel of BCG. Tuberculosis (Edinb.) 90: 329-332.
43. Aagaard, C., T. Hoang, J. Dietrich, P. J. Cardona, A. Izzo, G. Dolganov, G. K. Schoolnik, J. P. Cassidy, R. Billeskov, and P. Andersen. 2011. A multistage tuberculosis vaccine that confers efficient protection before and after exposure. Nat. Med. 17: 189-194.
44. + T-cell exhaustion and recovery. Proc. Natl. Acad. Sci. USA 107: 20453-20458.
45. Henao-Tamayo, M., A. Obregón-Henao, D. J. Ordway, S. B. Shang, C. G. Duncan, and I. M. Orme. 2012. A mouse model of tuberculosis reinfection. Tuberculosis (Edinb.) 92: 211-217.
46. Billeskov, R., C. Vingsbo-Lundberg, P. Andersen, and J. Dietrich. 2007. Induction of CD8 T cells against a novel epitope in TB10.4: correlation with mycobacterial virulence and the presence of a functional region of difference-1. J. Immunol. 179: 3973-3981.
47. Ryan, A. A., J. K. Nambiar, T. M. Wozniak, B. Roediger, E. Shklovskaya, W. J. Britton, B. Fazekas de St Groth, and J. A. Triccas. 2009. Antigen load governs the differential priming of CD8 T cells in response to the bacille Calmette Guerin vaccine or Mycobacterium tuberculosis infection. J. Immunol. 182: 7172-7177.
48. Radosevic, K., C. W. Wieland, A. Rodriguez, G. J. Weverling, R. Mintardjo, G. Gillissen, R. Vogels, Y. A. W. Skeiky, D. M. Hone, J. C. Sadoff, et al. 2007. Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon. Infect. Immun. 75: 4105-4115. (Pubitemid 47206310)
49. van Pinxteren, L. A. H., J. P. Cassidy, B. H. C. Smedegaard, E. M. Agger, and P. Andersen. 2000. Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells. Eur. J. Immunol. 30: 3689-3698. (Pubitemid 32005243)
50. Wang, J., M. Santosuosso, P. Ngai, A. Zganiacz, and Z. Xing. 2004. Activation of CD8 T cells by mycobacterial vaccination protects against pulmonary tuberculosis in the absence of CD4 T cells. J. Immunol. 173: 4590-4597. (Pubitemid 39280692)
51. + T cells require perforin to kill target cells and provide protection in vivo. J. Immunol. 181: 8595-8603.
52. Wille-Reece, U., B. J. Flynn, K. Loré, R. A. Koup, A. P. Miles, A. Saul, R. M. Kedl, J. J. Mattapallil, W. R. Weiss, M. Roederer, and R. A. Seder. 2006. Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates. J. Exp. Med. 203: 1249-1258. (Pubitemid 43736594)
53. Beveridge, N. E. R., D. A. Price, J. P. Casazza, A. A. Pathan, C. R. Sander, T. E. Asher, D. R. Ambrozak, M. L. Precopio, P. Scheinberg, N. C. Alder, et al. 2007. Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations. Eur. J. Immunol. 37: 3089-3100. (Pubitemid 350131288)
54. Kaveh, D. A., V. S. Bachy, R. G. Hewinson, and P. J. Hogarth. 2011. Systemic BCG immunization induces persistent lung mucosal multifunctional CD4 TEM cells which expand following virulent mycobacterial challenge. PLoS ONE 6: e21566.
55. Darrah, P. A., D. T. Patel, P. M. De Luca, R. W. B. Lindsay, D. F. Davey, B. J. Flynn, S. T. Hoff, P. Andersen, S. G. Reed, S. L. Morris, et al. 2007. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 13: 843-850. (Pubitemid 47038186)
56. Deeks, S. L., M. Clark, D. W. Scheifele, B. J. Law, M. Dawar, N. Ahmadipour, W. Walop, C. E. Ellis, and A. King. 2005. Serious adverse events associated with bacille Calmette-Guérin vaccine in Canada. Pediatr. Infect. Dis. J. 24: 538-541. (Pubitemid 40847528)
57. Hesseling, A. C., B. J. Marais, R. P. Gie, H. S. Schaaf, P. E. M. Fine, P. Godfrey-Faussett, and N. Beyers. 2007. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children. Vaccine 25: 14-18. (Pubitemid 44855247)
58. Hesseling, A. C., H. Rabie, B. J. Marais, M. Manders, M. Lips, H. S. Schaaf, R. P. Gie, M. F. Cotton, P. D. van Helden, R. M. Warren, and N. Beyers. 2006. Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children. Clin. Infect. Dis. 42: 548-558. (Pubitemid 43202529)
59. Hofstadler, G., K. Schmitt, G. Tulzer, L. Binder, and B. Brandstetter. 1998. BCG lymphadenitis in an HIV-infected child 9.5 years after vaccination. AIDS Patient Care STDS 12: 677-680. (Pubitemid 28447043)
60. Smith, E., S. Thybo, and J. Bennedsen. 1992. Infection with Mycobacterium bovis in a patient with AIDS: a late complication of BCG vaccination. Scand. J. Infect. Dis. 24: 109-110.
61. Lillebaek, T., A. Dirksen, E. Vynnycky, I. Baess, V. O. Thomsen, and A. B. Andersen. 2003. Stability of DNA patterns and evidence of Mycobacterium tuberculosis reactivation occurring decades after the initial infection. J. Infect. Dis. 188: 1032-1039. (Pubitemid 37268254)
62. Sonnenberg, P., J. Murray, J. R. Glynn, S. Shearer, B. Kambashi, and P. Godfrey-Faussett. 2001. HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet 358: 1687-1693. (Pubitemid 33124328)